Adverse Outcome Pathways (AOPs) are a tool for identifying the essential links between molecular events and adverse health outcomes. By participating in this innovative initiative, you’ll play a role in enhancing risk assessment, shaping regulations, and driving research that matters. We’re building a team of researchers, students, and subject matter experts to develop AOPs with guidance from leading AOP experts. Whether you’re early in your career or an established scientist, your expertise is valuable. To learn more about AOPs and how you can contribute follow this link: Nuclear Energy Agency (NEA) - Radiation and Chemical Adverse Outcome Pathway Joint Topical Group (Rad/Chem AOP JTG).
If you’re available, attend the Sept 17, 11am EST ALSDA AWG meeting, where an overview of AOPs and the project will be presented.
Dear Dr. Chauhan,
Thank you for sharing. I am a recent PhD in Cancer and Cell Biology with background in DNA damage response and repair and epithelial carcinogenesis using epidermal/mucosal organoid models. I am interested in participating and contributing to AOP projects. Could you please share details of the Sept 17th ALSDA AWG meeting?
Best,
Bidisha
@szol & @bidisha89.pal - I just added you in this Forum community to the ALSDAawg. You now should have the mtg invite information in your Meeting Calendar and all information on all AWG Meetings can always be found in your AWG Member Hub
I wanted to attend this meeting, but I missed it. Is there a recording of the meeting? If there is a meeting date planned in the future, I would like to add it to my agenda.